Cancer Survivor Intelligence Group

What we do

The ultimate aim is to be able to provide a robust evidence base upon which health and social care economies can build comprehensive after-care support programmes to maximise individuals quality of life, function and re-integration within society.

The lifetime population risk of developing cancer is 1 in 2 with over 50% living for at least 10 years beyond the time of diagnosis.  There are currently 2.5 million people living with and beyond a cancer diagnosis in the UK. Our work addresses the three outcomes that matter most to these individuals and their families:

1.    Am I going to survive?

2.    Am I going to be treated well?

3.    What am I going to be like after my cancer treatment?

Current research interests include site specific Patient Reported Outcomes (PROMs) research with prostate and bladder cancer and wide reaching general programmes of research into the late effects of cancer in both adults and children and young people. Specific focus is currently on mental and reproductive health outcomes for young people with cancer.

The group's work includes these programmes:


Who we are


Group Lead
Professor Adam Glaser

View our team members



Linda Roberts

0113 3430367


Funding Sources


Macmillan Cancer Support

Movember Foundation

Prostate Cancer UK

Yorkshire Cancer Research


Key publications

• Downing A, Wright P, Hounsome L, Selby P, Wilding S, Watson E, Wagland R, Kind P, Donnelly DW, Butcher H, Catto JWF, Cross W, Mason M, Sharp L, Weller D, Velikova G, McCaughan E, Mottram R, Allen M, Kearney T, McSorley O, Huws DW, Brewster DH, McNair E, Gavin A, Glaser AW. Quality of life in men living with advanced and localised prostate cancer: A United Kingdom population-wide patient-reported outcome study of 30,000 men. Lancet Oncology. In press 2018
  View Open Access version

• Friend AJ, Feltbower RG, Hughes EJ, Dye KP, Glaser AW. Mental health of long‐term survivors of childhood and young adult cancer: A systematic review. International Journal of Cancer. 2018; 143 (6):1279-1286. 
  View Open Access version
• Smith L, Glaser AW, Kinsey SE, Greenwood DC, Chilton L, Moorman AV, Feltbower RG. Long‐term survival after childhood acute lymphoblastic leukaemia: population‐based trends in cure and relapse by clinical characteristics. British Journal of Haematology. 2018; 182 (6):851-858. 
  View Open Access version
• Wallis CJD, Glaser A, Hu JC, Huland H, Lawrentschuk N, Moon D, Murphy DG, Nguyen PL, Resnick MJ, Nam RK. Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review. European Urology. 2018; 73 (1):11-20. 
  View Open Access version
• Frobisher C, Glaser A, Levitt GA, Cutter DJ, Winter DL, Lancashire ER, Oeffinger KC, Guha J, Kelly J, Reulen RC, Hawkins MM. Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up. British Journal of Cancer. 2017; 117 (11):1723-1731. 
• Wright EP, Downing A, Morris EJA, Corner J, Richards M, Sebag-Montefiore D, Finan P, Glaser AW. Identifying Social Distress: A Cross-Sectional Survey of Social Outcomes 12 to 36 Months After Colorectal Cancer Diagnosis. Journal of Clinical Oncology. 2015; Early Release Articles ():-. 
  View Open Access version
• Martin NE, Massey L, Stowell C, Bangma C, Briganti A, Bill-Axelson A, Blute M, Catto J, Chen RC, D’Amico AV, Feick G, Fitzpatrick JM, Frank SJ, Froehner M, Frydenberg M, Glaser A, Graefen M, Hamstra D, Kibel A, Mendenhall N, Moretti K, Ramon J, Roos I, Sandler H, Sullivan FJ, Swanson D, Tewari A, Vickers A, Wiegel T, Huland H. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. European Urology. 2015; 67 (3):460-467. 
• Glaser AW, Corner JL. Prostate Cancer Outcomes: The Three Questions. European Urology. 2015; 67 (3):357-358. 
• Downing A, Morris EJA, Richards M, Corner J, Wright P, Sebag-Montefiore D, Finan P, Kind P, Wood C, Lawton S, Feltbower R, Wagland R, Vernon S, Thomas J, Glaser AW. Health-related quality of life after colorectal cancer in England: A patient-reported outcomes study of individuals 12 to 36 months after diagnosis. Journal of Clinical Oncology. 2015; 33 (6):616-624. 
  View Open Access version
• Glaser A, Nicholson J, Taylor R, Walker D. Childhood cancer and proton beam therapy. BMJ. 2014; 349 (sep16 6):g5654-g5654.


Useful links